One week post VSV-GP-TAg boost, the frequency and number of circulating E7-specific CD8 T cells were negligeable in non-vaccinated mice, as expected from a lowly immunogenic tumor as TC-1, whereas KV vaccination induced a significant increase of antigen-specific CD8 T cells (Figure 3A). The gene discussed is CD8A; the disease is neoplasm.